WHO ICTRP trial
A Study of the Combination of Raltitrexed and Irinotecan Every Two Weeks as 2nd…
ChiCTR-ONC-12002767 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONC-12002767 |
|---|---|
| Public title | A Study of the Combination of Raltitrexed and Irinotecan Every Two Weeks as 2nd Line Treatment of Metastatic Colorectal Cancer |
| Scientific title | A Study of the Combination of Raltitrexed and Irinotecan Every Two Weeks as 2nd Line Treatment of Metastatic Colorectal Cancer |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | I+II (Phase I+Phase II) |
| Countries | China |
| Conditions | Colorectal Cancer |
| Interventions | Controlled:Raltitrexed and Irinotecan |
| Registration date | Nov 29, 2012 |
| Target size | Controlled:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: